These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9517872)

  • 21. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
    Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors associated with medical management of HIV infected persons in two French districts, 1993-1995].
    Schwoebel V; Delmas MS; Michon C; Hubert JS; Couturier E; Morlat P; Boué F; Simonpoli AS; Dabis F; Brunet JB
    Rev Epidemiol Sante Publique; 2000 Jan; 48(1):7-15. PubMed ID: 10740081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study.
    Furrer H; Opravil M; Rossi M; Bernasconi E; Telenti A; Bucher H; Schiffer V; Boggian K; Rickenbach M; Flepp M; Egger M;
    AIDS; 2001 Mar; 15(4):501-7. PubMed ID: 11242147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawal of prophylaxis against Pneumocystis carinii pneumonia.
    Feinberg J
    Lancet; 1999 Apr; 353(9161):1287. PubMed ID: 10218521
    [No Abstract]   [Full Text] [Related]  

  • 25. Racial differences in the use of drug therapy for HIV disease in an urban community.
    Moore RD; Stanton D; Gopalan R; Chaisson RE
    N Engl J Med; 1994 Mar; 330(11):763-8. PubMed ID: 8107743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
    Heffelfinger JD; Voetsch AC; Nakamura GV; Sullivan PS; McNaghten AD; Huang L
    PLoS One; 2009; 4(3):e5002. PubMed ID: 19319199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
    Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
    JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
    Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
    Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
    Cheung C; Shuter J
    Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
    Mezzaroma I; Giovannetti A; Pinter E; Ensoli F; Aiuti F
    AIDS; 1999 Dec; 13(17):2488-9. PubMed ID: 10597798
    [No Abstract]   [Full Text] [Related]  

  • 33. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first one hundred AIDS cases in Hong Kong.
    Lee SS; Lo YC; Wong KH
    Chin Med J (Engl); 1996 Jan; 109(1):70-6. PubMed ID: 8758375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of antiretroviral treatment and prophylaxis for opportunistic infections on survival of patients with AIDS].
    Gálvez Hermoso C; Blanco Quintana F; del Amo Valero J; Díez Ruiz-Navarro M; Soriano Vázquez V; González Lahoz J
    Rev Clin Esp; 2000 Apr; 200(4):187-92. PubMed ID: 10857401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children.
    Urschel S; Schuster T; Dunsch D; Wintergerst U; Hofstetter R; Belohradsky BH
    AIDS; 2001 Aug; 15(12):1589-91. PubMed ID: 11504999
    [No Abstract]   [Full Text] [Related]  

  • 37. Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.
    Degen O; ven Lunzen J; Horstkotte MA; Sobottka I; Stellbrink HJ
    AIDS; 2002 Jul; 16(10):1433-4. PubMed ID: 12131226
    [No Abstract]   [Full Text] [Related]  

  • 38. Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United Kingdom.
    Wall PG; Porter K; Noone A; Goldberg DJ
    AIDS; 1993 Nov; 7(11):1523-5. PubMed ID: 8280421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.